First-In-Human Study to Evaluate Safety And Pharmacokinetics of Single Escalating Doses of BCD-147 (Bispecific Anti-HER2/HER2 Antibody) in Healthy Subjects
Clinical trial NCT03912441 · COMPLETED
Trial details
- NCT number
- NCT03912441
- Sponsor
- Biocad
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-01-30
- Primary completion
- 2019-09-30
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.